Caris Life Sciences (CAI) Total Liabilities (2024 - 2026)

Caris Life Sciences' Total Liabilities history runs 3 years deep, the most recent figure standing at $568.9 million for Q1 2026.

• In Q1 2026, Total Liabilities fell 78.12% year-over-year to $568.9 million; the TTM figure through Mar 2026 stood at $568.9 million (down 78.12% YoY), while the FY2025 annual figure was $548.4 million, down 11.69% from the prior year.
• Total Liabilities was $568.9 million for Q1 2026 at Caris Life Sciences, up from $548.4 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $2.6 billion in Q1 2025 to a low of $502.2 million in Q2 2025.
• Historically, Total Liabilities has averaged $1.3 billion across 3 years, with a median of $594.9 million in 2024.
• Biggest YoY gain for Total Liabilities was 11.69% in 2025; the steepest drop was 79.27% in 2025.
• A 3-year view of Total Liabilities shows it stood at $620.9 million in 2024, then fell by 11.69% to $548.4 million in 2025, then gained by 3.75% to $568.9 million in 2026.
• The last three Total Liabilities figures came in at $568.9 million (Q1 2026), $548.4 million (Q4 2025), and $506.2 million (Q3 2025), per Business Quant data.